Home › WARF

WARF

News Story
11/3/2014
Posted by Mark Reback
A nonprofit advocacy group has asked the U.S. Supreme Court to overturn a decision by the Court of Appeals for the Federal Circuit that barred the group from challenging the validity of a controversial embryonic stem cell patent. Consumer Watchdog, represented by the Public Patent Foundation, filed a petition for certiorari Friday, asking the...
News Release
10/31/2014
Posted by John M. Simpson
WASHINGTON, DC – Consumer Watchdog and the Public Patent Foundation today asked the U.S Supreme Court to overturn a lower court’s decision and allow the two public interest groups to seek the cancellation of a patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF). In its petition, Consumer...
News Story
10/31/2014
Posted by Mark Reback
The thorny and unresolved question of whether life itself can be patented may come again before the U.S. Supreme Court, if it accepts a motion filed Friday by Santa Monica-based Consumer Watchdog. (H/T to David Jensen's California Stem Cell Report.) The issue isn't a new one either for the consumer group or the Court. Consumer Watchdog...
News Story
10/30/2014
Posted by Mark Reback
The California-based  challenge to WARF’s patent on human embryonic stem cells is headed for the United States Supreme Court.   The nation’s highest court is expected to be asked Friday to overturn an earlier appellate court decision and allow two public interest groups to seek to cancel the patent held by WARF, the Wisconsin...
News Story
10/30/2014
Posted by Mark Reback
The U.S. Supreme Court will be asked to intervene over a controversial embryonic stem cell patent, opponents of the patent said Thursday. Jeanne Loring, a stem cell scientist at The Scripps Research Institute, said the court will be asked Friday to overturn a lower court decision and allow the opponents to seek cancellation of the patent held by...
News Story
1/31/2014
Posted by Mark Reback
WASHINGTON (Legal Newsline) — The U.S. Patent and Trademark Office, in a federal court filing this month, argues that a consumer group challenging a patent on stem cells does not have standing to appeal the agency’s review decision. “Except at the behest of a party with a concrete and particularized interest in the question...
News Story
1/6/2014
Posted by Mark Reback
As scientists get closer to using embryonic stem cells in new treatments for blindness, spinal cord injuries and heart disease, a U.S. legal debate could determine who profits from that research. Consumer Watchdog, a nonprofit advocacy group, wants an appeals court to invalidate a University of Wisconsin-Madison’s patent for stem cells...
News Release
9/3/2013
Posted by John M. Simpson
WASHINGTON, DC – A patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF) “covers ineligible subject matter and was anticipated by and obvious” in view of earlier research, Consumer Watchdog and the Public Patent Foundation have told a federal appeals court. In a reply brief filed late last...
News Story
8/1/2013
Posted by Mark Reback
Last month, Consumer Watchdog filed its opening brief in an appeal of a Board decision affirming the patentability of U.S. Patent No. 7,029,913, arguing that the claims of the '913 patent are invalid because they cover ineligible subject matter and were anticipated and obvious.  The appeal arises from an inter partes reexamination of the...
News Story
7/8/2013
Posted by Mark Reback
Two US public interest groups have asked a federal appeals court to hear a challenge of a patent over human embryonic stem cells (hESCs). Consumer Watchdog, a non-profit consumer advocacy organisation based in Santa Monica, California, along with lawyers from the Public Patent Foundation (PPF), lodged an appeal from a decision by the US Patent and...